Meibomian gland dysfunction, dropout and distress: emerging therapies
- 8 April 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Eye
- Vol. 34 (9), 1494-1496
- https://doi.org/10.1038/s41433-020-0865-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prospective Trial of Intense Pulsed Light for the Treatment of Meibomian Gland DysfunctionInvestigative Ophthalmology & Visual Science, 2015
- One man's poison is another man's meat: Using azithromycin-induced phospholipidosis to promote ocular surface healthToxicology, 2014
- Topical diquafosol for patients with obstructive meibomian gland dysfunctionBritish Journal of Ophthalmology, 2013
- Oral Azithromycin for Treatment of Posterior BlepharitisCornea, 2011
- The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on the Epidemiology of, and Associated Risk Factors for, MGDInvestigative Ophthalmology & Visual Science, 2011
- The International Workshop on Meibomian Gland Dysfunction: Executive SummaryInvestigative Ophthalmology & Visual Science, 2011
- Pathogenic role of Demodex mites in blepharitisCurrent Opinion in Allergy and Clinical Immunology, 2010
- Topical Azithromycin Therapy for Meibomian Gland Dysfunction: Clinical Response and Lipid AlterationsCornea, 2010
- IPL technology: A reviewLasers in Surgery and Medicine, 2003
- Meibomian gland dysfunction in patients with Sjögren syndromeOphthalmology, 1998